Onchocerca volvulus infection prevalence and intensity in Logo and Nyarambe Health Zones in Ituri, Democratic Republic of the Congo in 2010 and in 2021–2023: results of screening for clinical trials of moxidectin versus ivermectin

Given that the reduction in infection prevalence and intensity in Logo HZ cannot be attributed to ivermectin distribution, it has to be due to reduction in infective vector biting rates, possibly linked to a recently proposed change in vector species triggered by land-use changes. Because SmfD reflects transmission events approximately 2-15 years earlier, infective vector biting rate assessment is needed to determine current transmission rates. Reduced transmission shifts macrofilariae age distribution toward older macrofilariae with lower reproductive capacity. Comparison of the results from the Phase 3 and the ongoing efficacy study might help determine whether drug susceptibility changes significantly with macrofilariae age. Should that be the case, transmission models evaluating the impact of mass drug administrations could be adjusted.

Authors

Institutions

Publication Details

Journal
Parasites & Vectors
Published
2026-03-16
DOI
https://doi.org/10.1186/s13071-025-07199-8
Primary Topic
Parasitic Diseases Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Onchocerca volvulus infection prevalence and intensity in Logo and Nyarambe Health Zones in Ituri, Democratic Republic of the Congo in 2010 and in 2021–2023: results of screening for clinical trials of moxidectin versus ivermectin

Germain Abhafule, Françoise Ngave, Sally Kinrade, Michel Vaillant et al.
Parasites & Vectors
Parasitic Diseases Research and Treatment
article

Onchocerca volvulus infection prevalence and intensity in Logo and Nyarambe Health Zones in Ituri, Democratic Republic of the Congo in 2010 and in 2021–2023: results of screening for clinical trials of moxidectin versus ivermectin

Germain Abhafule, Françoise Ngave, Sally Kinrade, Michel Vaillant, Anna Schritz, Deogratias Ucima Wonyarossi, Annette C. Kuesel, Amos Nyathirombo, Tony Ukety, Maurice M. Nigo, Beatriz Mosqueira, Mupenzi Mumbere, Christine Halleux, Germain Mambandu, Jöel Lonema Mande, Anuarite A. Raciu, Claude B. Uvon, Innocent A. Mananu, Gisèle L. Abeditho, Jules U. Upenjirwoth, Carine M. Aliang’o, Jean de Dieu N. Unega, Jean-Paul U. Uvoyo, Pascal T. Adroba, Didier Bakajika, Michel Mandro
article en

Abstract

Given that the reduction in infection prevalence and intensity in Logo HZ cannot be attributed to ivermectin distribution, it has to be due to reduction in infective vector biting rates, possibly linked to a recently proposed change in vector species triggered by land-use changes. Because SmfD reflects transmission events approximately 2-15 years earlier, infective vector biting rate assessment is needed to determine current transmission rates. Reduced transmission shifts macrofilariae age distribution toward older macrofilariae with lower reproductive capacity. Comparison of the results from the Phase 3 and the ongoing efficacy study might help determine whether drug susceptibility changes significantly with macrofilariae age. Should that be the case, transmission models evaluating the impact of mass drug administrations could be adjusted.

Parasites & Vectors
Luxembourg Institute of Health (LU), World Health Organization (CH), Université Shalom de Bunia (CD), Programme National Multisectoriel de Lutte contre le sida (CD)
Openalex Percentile: Top 21%
Parasitic Diseases Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.